Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...

A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...

A new study finds that prior herpesvirus infections are linked to a faster age-related increase in blood biomarkers ...

The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically modifying HSV-1 and administering it to patients with treatment-resistant, ...

Introduction: Herpes zoster is the reactivation of the varicella zoster virus (VZV), which remained quiescent in the Gasser ...

One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.

Scientists found that a genetically engineered herpes simplex virus, when combined with immunotherapy, reduced or eliminated ...

The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted). Shingrix is indicated for the preven ...

Could common viruses silently influence your brain health? Discover what new research reveals about herpes and dementia.

A genetically modified herpes simplex virus, called RP1, has now been shown to destroy advanced melanoma tumors, even when ...